Discordance: can we capitalize on it to better personalize atherosclerosis treatment?

Atherosclerosis. 2013 Aug;229(2):504-6. doi: 10.1016/j.atherosclerosis.2013.04.018. Epub 2013 Apr 20.
No abstract available

Keywords: Coronary artery calcium; Lipids; Risk; Subclinical atherosclerosis.

Publication types

  • Comment

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Apolipoprotein A-I / blood*
  • Apolipoproteins B / blood*
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / ethnology*
  • Cholesterol, LDL / blood*
  • Coronary Artery Disease / metabolism*
  • Ethnicity / statistics & numerical data*
  • Female
  • Humans
  • Lipoprotein(a) / blood*
  • Male
  • Vascular Calcification / metabolism*

Substances

  • Anticholesteremic Agents
  • Apolipoprotein A-I
  • Apolipoproteins B
  • Cholesterol, LDL
  • Lipoprotein(a)